Logos Global Management LP boosted its position in shares of COMPASS Pathways by 349.3% in the second quarter. Logos Global Management LP now owns 1,159,030 shares of the company’s stock valued ...

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on COMPASS Pathways (CMPS – Research Report) today and set a price target of ...

Compass Pathways announced an underwritten offering of American Depositary Shares (ADSs) and pre-funded warrants, expected to raise approximately $150 million, with the potential to reach $353 ...

COMPASS Pathways plc has a twelve month low of $3.16 and a twelve month high of $12.75. COMPASS Pathways ( NASDAQ:CMPS – Get Free Report ) last announced its earnings results on Thursday ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten ...

LONDON & NEW YORK, January 10, 2025--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental ...

Compass Pathways (NASDAQ:CMPS) shares rose nearly 9% premarket on Friday after the biotechnology company priced a securities offering to raise up to $353M. The company is offering ~24.01M American ...

Rodman & Renshaw maintained a Buy rating on Compass Pathways (NASDAQ:CMPS) but significantly reduced the 12-month price ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten ...